- Home
- ยป
- Our Products
- »
- Pharma Tablets
Pharma Tablets
Clotrimazole Vaginal Tablets
| Composition | Each pessary contains |
| Dosage | As directed by the Physician |
| Packaging Size | 1 x 6 Tablets |
| Strength | 500 mg |
| Packaging Type | Strips, Standard |
| Usage | Industrial,Commerical |
| Tablet/Capsule Size | Tablet |
Additional Information:
- Packaging Details: 1 x 6 Tablets in printed carton with pack insert.
Aceclofenac & Paracetamol Tablets
| Packaging Size | 20 x 10 Blister |
| Brand | DR. DEVMOL ACE |
| Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
| Prescription/Non prescription | Prescription |
| Also gives | Third Party Manufacturing |
| Form | Tablet |
| Country of Origin | Made in India |
Store in a dry place, protect from sunlight.
Additional Information:
- Packaging Details: 20 x 10 Tablets in Printed Carton.
DEVKAVIR ( Entecavir Tableta USP 0.5 )
Product Brochure
| Strength | 0.5 mg |
| Pack Size | 1*10 Tablet |
| Pack Type | Box |
| Brand Name | DEVKAVIR |
| Manufacturer | DEVLIFE CORPORATION PVT LTD |
| Country of Origin | Made in India |
Store below 30°C. Protect from light & moisture.
Additional Information:
- Packaging Details: 3 X 10 Alu Alu Blisters
DEVLAMER (Sevelamer Hydrochloride Tablet 800 mg)
Product Brochure
| Strength | 800 mg |
| Packaging Size | 10*10 Tablets |
| Brand | Devlamer |
| Shelf Life | 3 yaer |
Each Film Coated Tablet Contains:Sevelamer Hydrochloride ………….800 mg Excipients………………………............q.sColour: Titanium Dioxide BPINDICATIONS :DEVLAMER is indicated for:Control of hyperphosphatemia in adult patients receivinghaemodialysis or peritoneal dialysis and in patients with chronic kidney disease (CKD) DEVLAMER should be used within the context of a multiple therapeutic approach, which could include calcium supplement, 1,25-dihydroxy Vitamin D3 or one of its analogues to control the development of renal bone disease.
DOSAGE AND ADMINISTRATION :The recommended starting dose of DEVLAMER is 2.4 or 4.8 g/day. DEVLAMER must be taken 3x per day with meals.DEVLAMER should be taken with food and not on an empty stomach.
SIDE EFFECTS :Very Common: Nausea, vomiting.Common: Diarrhoea, dyspepsia, flatulence, upper abdominal pain, constipation.Very Rare: HypersensitivityNot Known: Intestinal obstruction, ileus/subileus, intestinal perforation, Gastrointestinal hemorrhage, intestinal ulceration, gastrointestinal necrosis, colitis, intestinal mass, Pruritus, rashDRUG INTERACTIONS :Interaction studies have not been conducted in patients on dialysis.DEVLAMER decreased the bioavailability of ciprofloxacin by approximately 50%.Caution should be exercised when prescribing DEVLAMER to patients taking Anti-arrhythmics and anti-seizure medicinal products.Reduced levels of ciclosporin, mycophenolate mofetil and tacrolimus have been reported in transplant patients when coadministered with DEVLAMER.Co-administered DEVLAMER and levothyroxine causes increase in thyroid stimulating hormone (TSH).
WARNINGS AND PRECAUTION : Caution should be exercised when DEVLAMER is used in patients with following disorders:Swallowing disordersActive inflammatory bowel diseaseGastrointestinal motility disorders including untreated or severe gastroparesis, diverticulosis retention of gastric contents and abnormal or irregular bowel motionPatients with a history of major gastrointestinal surgery.
PREGNANCY AND LACTATION :The safety of DEVLAMER has not been established in pregnant and breast-feeding women. It should only be given if clearly needed and after a careful risk/benefit analysis has been conducted for both the mother and the infant.
OVERDOSAGE :The symptoms observed in case of overdose are similar to Side effects including mainly constipation and other known gastrointestinal disorders.Appropriate symptomatic treatment should be provided.CONTRAINDICATION :Hypersensitivity to active substance or to any of the excipientsHypophosphataemiaBowel obstruction.STORAGE : Store below 30°C. Protect from moisture. Keep out of reach of children.
PRESENTATION :10 x 10 Tablets in printed carton with pack insert.
Calcium with Vitamin D3 with Minerals (OSTEOCA)
| Form | Tablets |
| Packaging Size | 2x15 |
| Packaging Type | Blister |
| Brand | OSTEOCA |
| Usage / Application | Commercial |
| Prescription Required | Yes |
| Manufacturer | DEVLIFE CORPORATION PVT. LTD. |
| Country of Origin | Made in India |
Color : Indigocarmine & Titanium Dioxide
Indications:Osteoca is recommended as a Nutritional Supplement for Calcium, Vitamins and Minerals.
Dosage and Administration:Two Tablets with or immediately after your main meal. Do not chew. Swallow whole with water.
Additional Information:
- Packaging Details: 2x15 Tablets in printed carton with pack insert.
Loperamide HCl Capsules ( IMODEV)
Product Brochure
| Pack Size | 10*10 Tablets |
| Pack Type | Strips |
| Brand Name | IMODEV |
Dosage : As directed by the Physician.
Store in a dry place below 30°C. Protect from light.
Keep out of reach of children.
Paroxetine Tablets 20 mg
| Composition | Each film coated tablet contains |
| Form | Tablets |
| Packaging Size | 1 x 10 Tablets |
| Usage/Application | Commercial |
| Brand Name | PAXETIN |
| Dosage | As directed by the Physician. |
| Packaging Type | Alu Alu Strip |
| Also Gives | Third Party Manufacturing |
| Type Of Medicines | Allopathic |
| Shelf Life | 3 Years |
| Treatment | Selective Serotonin Reuptake Inhibitors (SSRIs) or Antidepressant. |
Each film coated tablet contains :
Paroxetine Hydrochloride USP
Eq. to Paroxetine ................. 20 mg
Excipients ................................ q.s.
Colour: Indigo Carmine & Titanium Dioxide
INDICATION:
Paroxetine tablet is indicated in the treatment of:
- Major Depressive Episode
- Obsessive Compulsive Disorder
- Panic Disorder with and without agoraphobia
- Social Anxiety Disorders/Social phobia
- Generalised Anxiety Disorder
- Post-traumatic Stress Disorder
DOSAGE AND ADMINISTRATION:
Posology
Major Depressive Episode: 20 mg daily.
Obsessive Compulsive Disorder & Panic Disorder: 40 mg daily.
Social Anxiety Disorder/Social Phobia: 20 mg daily.
Generalised Anxiety Disorder: 20 mg daily.
Post-Traumatic Stress Disorder: 20 mg daily.
Specification :
Indicated in the treatment of:
- Major Depressive Episode
- Obsessive Compulsive Disorder
- Panic Disorder with and without agoraphobia
- Social Anxiety Disorders/Social phobia
- Generalised Anxiety Disorder
- Post-traumatic Stress Disorder
Additional Information:
- Packaging Details: 1 x 10 Alu Alu Strip in printed carton with pack insert.
HEP - C - DEV - VE ( Sofosbuvir 400 mg & Velpatasvir 100 mg Tablets )
| Strength | 400 mg+ 100 mg |
| Packaging Size | 28 Tablets |
Sofosbuvir ............400 mg
Velpatasvir ............100 mg
Excipients ..............q.s.
Additional Information:
- Packaging Details: 28 Tablets